VoluMetrix
PrivateLast Round
Accelerator
Feb 26, 2026
Total Funding Raised
$5.99M
Company Overview
VoluMetrix is a biotechnology company that develops non-invasive vital monitoring technology, including its flagship NIVAHF device for heart failure patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VoluMetrix Comparables
Compare VoluMetrix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ventric Health | 85% | |
| Cardiosense | 84% | |
| Acorai | 82% |
VoluMetrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 26, 2026 | ||||
| Grant | May 30, 2023 | ||||
| Grant | Apr 30, 2023 | ||||
| Grant | Jun 15, 2021 | ||||
| Grant | Oct 30, 2020 |
Key People
Founding team and executive leadership
VoluMetrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nashville Entrepreneur Center | Accelerator |
| NIH RADx | Grant |
| Tennessee Technology Development Corporation | Grant |
| BioFlorida, Inc. | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Food and Drug Administration | Grant |
| Pennsylvania Pediatric Medical Device Consortium | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors grew 57% MoM.
- May 30, 2023
Secured $3M from National Heart, Lung, and Blood Institute and NIH RADx.
VoluMetrix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VoluMetrix's valuation, stock price, and market status.
Is VoluMetrix a public or private company?
VoluMetrix is a private company.
What is the current stock price of VoluMetrix?
VoluMetrix is a private company with no public stock price. No recent secondary market data is available.
How much is VoluMetrix worth (valuation)?
Valuation information for VoluMetrix is not publicly available.
Can I buy VoluMetrix stock?
VoluMetrix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VoluMetrix's last funding round?
VoluMetrix's most recent funding round was Accelerator on February 26, 2026.
Who are the main investors in VoluMetrix?
Key investors in VoluMetrix include Nashville Entrepreneur Center, NIH RADx, BioFlorida, Inc., National Heart, Lung, and Blood Institute, Pennsylvania Pediatric Medical Device Consortium.
Will VoluMetrix IPO soon?
No public IPO plans have been announced for VoluMetrix.
How can I track VoluMetrix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VoluMetrix's secondary market activity and sign up for updates.